FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095527325> ?p ?o ?g. }

• W2095527325 abstract "A 50-year-old man from Mymensingh district, Bangladesh, presented with a 3-month history of non-pruritic, painless hypopigmented papules, and plaques, beginning on the face and subsequently spreading to the forearms, torso, and legs (Figures 1–4) Fifteen months before the onset of skin lesions, the patient had visceral leishmaniasis (kala-azar), successfully treated with 30 intramuscular injections of sodium stibogluconate (SSG). Polymerase chain reaction showed Leishmania donovani DNA in a buffy coat specimen.Figure 1.The patient has hypopigmented papules and plaques scattered over the face, most concentrated peri-orally and on the cheeks, common areas of involvement for post-kala-azar dermal leishmaniasis (PKDL). The patient consented to having his picture published ...Figure 4.The patient has hypopigmented papules and plaques on both forearms. The absence of sensorineural changes helps to distinguish post-kala-azar dermal leishmaniasis (PKDL) from leprosy, which commonly presents with hypopigmented macules or patches associated ...Figure 2.Hypopigmented papules are seen on the patient's back. The lesions are roughly symmetrical, a common characteristic of post-kala-azar dermal leishmaniasis (PKDL), and are painless and non- pruritic.Figure 3.Hypopigmented papules on the abdomen.Post-kala-azar dermal leishmaniasis (PKDL) is a chronic skin rash usually seen in apparently cured kala-azar patients in East Africa and South Asia. In the Indian subcontinent, the cumulative PKDL incidence after kala-azar is 5–10%.1 The PKDL usually presents with erythematous or hypopigmented papules or macules, sometimes progressing to plaques or nodules. Kala-azar patients treated with antimonial drugs may have poorer immune recovery and a higher risk of subsequent PKDL compared with those treated with amphotericin formulations.2 The only PKDL treatment regimens with proven efficacy in South Asia consist of 120 SSG injections over 6 months or miltefosine 2.5 mg/kg/day for 12 weeks. The PKDL patients are infectious to the sand fly vector and are thought to represent an important parasite reservoir in the anthroponotic transmission cycle of visceral leishmaniasis in South Asia.1" @default.
• W2095527325 created "2016-06-24" @default.
• W2095527325 creator A5016023875 @default.
• W2095527325 creator A5020950762 @default.
• W2095527325 creator A5082622069 @default.
• W2095527325 date "2011-08-01" @default.
• W2095527325 modified "2023-09-26" @default.
• W2095527325 title "Post-Kala-Azar Dermal Leishmaniasis in Mymensingh, Bangladesh" @default.
• W2095527325 cites W1514702282 @default.
• W2095527325 cites W2058318327 @default.
• W2095527325 doi "https://doi.org/10.4269/ajtmh.2011.11-0128" @default.
• W2095527325 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3144810" @default.
• W2095527325 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21813832" @default.
• W2095527325 hasPublicationYear "2011" @default.
• W2095527325 type Work @default.
• W2095527325 sameAs 2095527325 @default.
• W2095527325 citedByCount "3" @default.
• W2095527325 countsByYear W20955273252013 @default.
• W2095527325 countsByYear W20955273252017 @default.
• W2095527325 countsByYear W20955273252019 @default.
• W2095527325 crossrefType "journal-article" @default.
• W2095527325 hasAuthorship W2095527325A5016023875 @default.
• W2095527325 hasAuthorship W2095527325A5020950762 @default.
• W2095527325 hasAuthorship W2095527325A5082622069 @default.
• W2095527325 hasBestOaLocation W20955273252 @default.
• W2095527325 hasConcept C142724271 @default.
• W2095527325 hasConcept C16005928 @default.
• W2095527325 hasConcept C2776555147 @default.
• W2095527325 hasConcept C2778689377 @default.
• W2095527325 hasConcept C2780122544 @default.
• W2095527325 hasConcept C2780695269 @default.
• W2095527325 hasConcept C2781333301 @default.
• W2095527325 hasConcept C2781417161 @default.
• W2095527325 hasConcept C71924100 @default.
• W2095527325 hasConceptScore W2095527325C142724271 @default.
• W2095527325 hasConceptScore W2095527325C16005928 @default.
• W2095527325 hasConceptScore W2095527325C2776555147 @default.
• W2095527325 hasConceptScore W2095527325C2778689377 @default.
• W2095527325 hasConceptScore W2095527325C2780122544 @default.
• W2095527325 hasConceptScore W2095527325C2780695269 @default.
• W2095527325 hasConceptScore W2095527325C2781333301 @default.
• W2095527325 hasConceptScore W2095527325C2781417161 @default.
• W2095527325 hasConceptScore W2095527325C71924100 @default.
• W2095527325 hasLocation W20955273251 @default.
• W2095527325 hasLocation W20955273252 @default.
• W2095527325 hasLocation W20955273253 @default.
• W2095527325 hasLocation W20955273254 @default.
• W2095527325 hasOpenAccess W2095527325 @default.
• W2095527325 hasPrimaryLocation W20955273251 @default.
• W2095527325 isParatext "false" @default.
• W2095527325 isRetracted "false" @default.
• W2095527325 magId "2095527325" @default.
• W2095527325 workType "article" @default.